This is the PR that started the sudden rise in IVEH stock price last week:
CLAREMORE, Okla.--(BUSINESS WIRE)--Feb. 15, 2001--Ives Health Company (OTCBB:IVEH - news) announced today that T-Factor® has been successful in increasing T-Cell (CD-4) cell counts in HIV patients by an average of 18 cells per milliliter of blood per month, with some patients averaging as much as 65 cells per milliliter of blood per month.
The results of this ground-breaking study come as Ives releases the drug, which has virtually no side effects, to the public on its website at iveshealth.com.
The Java Project was a landmark AIDS study carried out by Dr. Slayton-Bedeen, an Immunologist and T-Factor® Founder, along with the World Health Organization (WHO) in Jakarta and Bangkok. The project found that new hormonal inhibitors of the Human Immunodeficiency Virus (HIV), like T-Factor®, might initiate profound and sustained suppression of HIV replication. The T-Factor® formula was administered to 186 HIV-Positive patients of Asian descent with elevated HIV RNA and decreased CD-4 counts over a period of 24 weeks. The results were dramatic, with over 80% of patients experiencing documented decreases in HIV RNA and enhanced CD-4 counts after 24 weeks.
Keith Ives, President and Founder of Ives Health Company stated: ``This is incredible news. There has been a revelation occurring in HIV healthcare that has linked T-Cell loss to immune system deficiency. The Java Project was the first study to be conducted on this type of natural remedy. Anyone who is skeptical of the ability of natural drugs to succeed where man-made chemicals can't, will surely be forced to take another look. If we can gain the support of the media, our investors, and HIV patients worldwide, Ives Health Company could help millions of people.''
The T-Factor® formula, acquired by Ives Health Company in 1998, is all-natural, has virtually no side effects, and is readily available over the Internet at iveshealth.com. T-Factor® costs less than $3.00 per day versus $80.00 per day for current HIV drug therapies.
Mr. Ives continued: ``A person whose CD-4 count drops below 350 is considered to be in the final stages of immune deficiency and could die from any infection or illness. By dramatically increasing a person's CD-4 cell count, that person stands a better chance of survival. While T-Factor® is not a cure, it still offers hope that this treatment can prolong HIV patients' life spans and, more importantly, improve their quality of life, until a cure is found.''
New studies are ongoing in the United States and recently began in Europe. Findings will be released as the data is reported and validated.
About Ives Health Company
Ives Health Company is committed to improving consumers ``Total Health'' through their high-quality natural remedies and homeopathic medicines. Ives product formulations use 98.3% pure natural ingredients and deliver an astounding 90% of the active ingredients into the bloodstream. The Company's products compete in the $99.2 billion diet and nutritional product arena under the following branded names: Pharmacy Health and Diet Program®, T-Factor® Immune Enhancement System, Vegi Bears(TM) (a nutritional snack) and other natural remedies for aches & pains, acne (a non-topical oral treatment), allergy, antacid, arthritis, cough & sore throat, energy, headache, sinus, PMS relief, prostate relief, cholesterol control among others. Please visit iveshealth.com to purchase or to learn more about the Ives family of homeopathic medicines, weight management and natural remedy products.
For Ives Health Company, Claremore, Okla.:
Strategic Communications
Investor Relations, 775/828-6576
or
www.iveshealth.co |
